Detail of > 81156-93-6
- CAS Number:
- 81156-93-6
- Name:
Glycine,L-arginyl-L-arginyl-L-leucyl-L-isoleucyl-L-a-glutamyl-L-a-aspartyl-L-alanyl-L-a-glutamyl-L-tyrosyl-L-alanyl-L-alanyl-L-arginyl-
- Formula:
- C64H106 N22 O21
- Molecular Structure:

- Synonyms:
- 101:PN: FR2862981 SEQID: 101 unclaimed sequence; 101: PN: WO2004033476 SEQID: 101unclaimed sequence; 11: PN: WO2006094704 SEQID: 1 unclaimed sequence; 124: PN:US20030119021 SEQID: 121 unclaimed sequence; 12: PN: CA2504920 SEQID: 12 unclaimedsequence; 12: PN: US20060134693 SEQID: 12 unclaimed sequence; 13: PN:WO2009149577 PAGE: 25 unclaimed sequence; 14: PN: WO03082907 SEQID: 14unclaimed sequence; 15: PN: CA2589393 SEQID: 6 unclaimed sequence; 168: PN:WO2004069191 PAGE: 75 unclaimed sequence; 16: PN: US20030108986 SEQID: 29unclaimed sequence; 190: PN: US20070037134 SEQID: 209 unclaimed sequence; 1:PN: US20030072738 PAGE: 8 unclaimed sequence; 1: PN: WO2007084631 PAGE: 28unclaimed sequence; 27: PN: US20050100951 SEQID: 37 unclaimed sequence; 3: PN:US20030161893 SEQID: 3 unclaimed sequence; 3: PN: US20050215629 SEQID: 3unclaimed sequence; 40: PN: US20050037343 SEQID: 37 unclaimed sequence; 4: PN:US6335176 SEQID: 5 unclaimed sequence; 4: PN: WO03057730 SEQID: 4 unclaimedsequence; 5: PN: WO0017329 SEQID: 7 unclaimed sequence; 5: PN: WO02077153SEQID: 5 unclaimed sequence; 74: PN: US20040086966 SEQID: 74 unclaimed protein;74: PN: US20050155090 SEQID: 74 unclaimed sequence; 74: PN: US20070213508SEQID: 74 unclaimed sequence; 74: PN: US20070213510 SEQID: 74 unclaimedsequence; 74: PN: US20070238862 SEQID: 74 unclaimed sequence; 7: PN:US20040010045 SEQID: 7 unclaimed sequence; 7: PN: WO03092616 SEQID: 7 unclaimedsequence; Peptide RRsrc (synthetic tyrosine protein kinase substrate); RR-SRC;Src-Peptide
- Molecular Weight:
- 1519.68
- Solubility:
- H2O: soluble
- Appearance:
- lyophilized powder
- Safety:
- 22-24/25Details
Related products
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 87805-34-3Glucagon-like peptide I(human)
- 81156-93-6Glycine,L-arginyl-L-arginyl-L-leucyl-L-isoleucyl-L-a-glutamyl-L-a-aspartyl-L-alanyl-L-a-glutamyl-L-tyrosyl-L-alanyl-L-alanyl-L-arginyl-
- 2743-40-0L-Leucine Ethyl ester Hydrochloride
- 88495-54-9L-1-Boc-Nipecotic acid
- 13864-01-2Lanthanum hydride(LaH3)
- 3437-84-1Peroxide,bis(2-methyl-1-oxopropyl)
- 57576-41-7Norcepharadione B
- 850429-50-42H-Pyran-4-acetonitrile,tetrahydro-
- 5735-53-52H-1,4-Benzoxazine,3,4-dihydro-
- 1304-39-8Barium selenide (BaSe)
- 1303-11-3Indium arsenide (InAs)
- 52986-70-6Isoquinoline,6-methoxy-
- 26717-67-9Propanedioic acid,2-ethyl-, 1,3-dimethyl ester
- 15684-36-3Borate(1-),tetrafluoro-, nickel(2+) (2:1), hexahydrate (9CI)
- 626-34-6Ethyl 3-aminocrotonate
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
United States(1)
- Business Type:
- Importer/Exporter(1)
- Certificates:
- ISO (0) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor
- Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor. Wedegaertner, Philip B.; Gill, Gordon N. (Dep. Chem., Univ. California, San Diego, La Jolla, CA 92093-0650, USA). Arch. Biochem. Biophys., 292(1), 273-80 (English) 1992.In this article, certain chemicals are used. Some of their cas registry numbers are 139123-04-9 and 81156-93-6 CODEN: ABBIA4. ISSN: 0003-9861. DOCUMENT TYPE: Journal CA Section: 7 (Enzymes) Section cross-reference(s): 2 The carboxyl terminal domain of the epidermal growth factor receptor (EGFR) is an important regulatory region in mediating the tyrosine kinase-dependent biol. effects of EGF. The effect of a 164-amino-acid carboxyl deletion of the EGFR or the EGFR cytoplasmic kinase domain on in vitro tyrosine kinase activity was assessed. C'-terminal truncation of the EGFR resulted in dependence on Mn2+ for full activity. The EGFR kinase domain (kd EGFR) and the C'-terminally truncated kinase domain (kd c'1022 EGFR) also exhibited a strong preference for Mn2+ compared to Mg2+, with kd c'1022 EGFR being completely inactive in the presence of Mg2+ alone. Sphingosine or ammonium sulfate specifically activated both kd EGFR and kd c'1022 EGFR. EGFR and c'1022 EGFR displayed similar EGF-stimulated in vitro tyrosine kinase activities; however, kd EGFR was 5- to 10-fold more active in vitro than kd c'1022 EGFR. Thus, the regulatory contribution of the C'-terminus is most evident when the EGFR ligand binding domain is removed. These results indicate that an intact EGFR C'-terminus is necessary for the protein to assume a fully active conformation. .
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

